EP Patent

EP3590941B1 — Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereof

Assigned to Beijing Scitech MQ Pharmaceuticals Ltd · Expires 2023-11-22 · 2y expired

What this patent protects

Patent listed against tivozanib-hydrochloride.

Drugs covered by this patent

tivozanib-hydrochloride (TIVOZANIB HYDROCHLORIDE)

Patent Metadata

Patent number: EP3590941B1
Jurisdiction: EP
Classification: —
Expires: 2023-11-22
Drug substance claim: No
Drug product claim: No
Assignee: Beijing Scitech MQ Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.